KGA-2727
KGA-2727 is a potent and selective SGLT1 inhibitor, with Kis of 97.4 nM and 43.5 nM for human and rat SGLT1, respectively. The selectivity ratios (Ki for SGLT2/Ki for SGLT1) of KGA-2727 are 140 (human) and 390 (rat) . KGA-2727 for the treatment of diabete.KGA-2727, which has a pyrazole-O-glucoside structure, as the first selective SGLT1 inhibitor.
Product Specifications
CAS Number
666842-36-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
536.62
Molecular Formula
C26H40N4O8
Notes
Research use only, not for human use.
Receptor
SGLT1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog